Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

2-1-2020

Antiviral inflammation during early pregnancy reduces placental
and fetal growth trajectories
Kelly J. Baines
Schulich School of Medicine & Dentistry

Amanda M. Rampersaud
Schulich School of Medicine & Dentistry

Dendra M. Hillier
Schulich School of Medicine & Dentistry

Mariyan J. Jeyarajah
Schulich School of Medicine & Dentistry

Grace K. Grafham
Schulich School of Medicine & Dentistry

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Baines, Kelly J.; Rampersaud, Amanda M.; Hillier, Dendra M.; Jeyarajah, Mariyan J.; Grafham, Grace K.;
Eastabrook, Genevieve; Lacefield, James C.; and Renaud, Stephen J., "Antiviral inflammation during early
pregnancy reduces placental and fetal growth trajectories" (2020). Paediatrics Publications. 1197.
https://ir.lib.uwo.ca/paedpub/1197

Authors
Kelly J. Baines, Amanda M. Rampersaud, Dendra M. Hillier, Mariyan J. Jeyarajah, Grace K. Grafham,
Genevieve Eastabrook, James C. Lacefield, and Stephen J. Renaud

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1197

Antiviral Inflammation during Early
Pregnancy Reduces Placental and Fetal
Growth Trajectories
This information is current as
of August 8, 2022.

Kelly J. Baines, Amanda M. Rampersaud, Dendra M.
Hillier, Mariyan J. Jeyarajah, Grace K. Grafham, Genevieve
Eastabrook, James C. Lacefield and Stephen J. Renaud

Supplementary
Material
References

http://www.jimmunol.org/content/suppl/2019/12/26/jimmunol.190088
8.DCSupplemental
This article cites 72 articles, 17 of which you can access for free at:
http://www.jimmunol.org/content/204/3/694.full#ref-list-1

Why The JI? Submit online.
• Rapid Reviews! 30 days* from submission to initial decision
• No Triage! Every submission reviewed by practicing scientists
• Fast Publication! 4 weeks from acceptance to publication
*average

Subscription
Permissions
Email Alerts

Information about subscribing to The Journal of Immunology is online at:
http://jimmunol.org/subscription
Submit copyright permission requests at:
http://www.aai.org/About/Publications/JI/copyright.html
Receive free email-alerts when new articles cite this article. Sign up at:
http://jimmunol.org/alerts

The Journal of Immunology is published twice each month by
The American Association of Immunologists, Inc.,
1451 Rockville Pike, Suite 650, Rockville, MD 20852
Copyright © 2020 by The American Association of
Immunologists, Inc. All rights reserved.
Print ISSN: 0022-1767 Online ISSN: 1550-6606.

Downloaded from http://www.jimmunol.org/ by guest on August 8, 2022

J Immunol 2020; 204:694-706; Prepublished online 27
December 2019;
doi: 10.4049/jimmunol.1900888
http://www.jimmunol.org/content/204/3/694

The Journal of Immunology

Antiviral Inflammation during Early Pregnancy Reduces
Placental and Fetal Growth Trajectories
Kelly J. Baines,* Amanda M. Rampersaud,* Dendra M. Hillier,* Mariyan J. Jeyarajah,*
Grace K. Grafham,* Genevieve Eastabrook,†,‡ James C. Lacefield,x,{,‖ and Stephen J. Renaud*,‡

S

uccessful pregnancy requires a delicate balance between
proinflammatory and anti-inflammatory pathways. Pathological inflammation disrupts this balance and is an underlying feature of a spectrum of prevalent pregnancy complications (1).
In humans, it is difficult to discern whether inflammation is a cause
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or consequence of a compromised pregnancy, but circumstantial and
epidemiological evidence implicate inflammation as a component
of disease pathogenesis (2, 3). A direct link between inflammation
and various pregnancy pathological conditions has been demonstrated in animal models in which dams are exposed to microbial
products called pathogen-associated molecular patterns, resulting
in changes in labor onset and alterations in fetal survival, growth,
and developmental trajectories (4–7). However, the underlying
mechanisms through which inflammation compromises fetal
growth and development are still unknown.
Fetal growth restriction (FGR; also known as intrauterine growth
restriction) is a serious pregnancy complication associated with
failure of a fetus to grow to its full potential. Although an accepted
definition and consensus diagnosis of FGR are lacking, it is generally defined as fetal weight below the 10th percentile for that
population and gestational age while considering sex, race, and
genetic growth potential (8). Identifying cases of morbid FGR
versus healthy fetuses that are constitutionally small remains a
significant problem. In general, FGR is one of the most important
indicators of pregnancy outcome including prematurity, stillbirth,
intrapartum fetal distress, hypoglycemia, and meconium aspiration pneumonia (9) as well as long-term growth impairments and
permanent pulmonary, metabolic, endocrine, and neurobehavioral
sequelae (10). FGR may be caused by multiple factors, including
chromosomal aberrations, vascular abnormalities, and infections
and in many cases is associated with inflammation as an underlying feature (11). In 40–50% of cases, the cause of FGR is idiopathic and attributed to maldevelopment or dysfunction of the
placenta.
The placenta is the extraembryonic organ that ensures an adequate nutrient and gas supply for the fetus and as such is a critical
regulator of fetal growth and development. The efficiency of
transferring substrates needed for fetal growth, including oxygen,
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Many viruses are detrimental to pregnancy and negatively affect fetal growth and development. What is not well understood is
how virus-induced inflammation impacts fetal–placental growth and developmental trajectories, particularly when inflammation
occurs in early pregnancy during nascent placental and embryo development. To address this issue, we simulated a systemic virus
exposure in early pregnant rats (gestational day 8.5) by administering the viral dsRNA mimic polyinosinic:polycytidylic acid
(PolyI:C). Maternal exposure to PolyI:C induced a potent antiviral response and hypoxia in the early pregnant uterus, containing
the primordial placenta and embryo. Maternal PolyI:C exposure was associated with decreased expression of the maternally
imprinted genes Mest, Sfrp2, and Dlk1, which encode proteins critical for placental growth. Exposure of pregnant dams to PolyI:C
during early pregnancy reduced fetal growth trajectories throughout gestation, concomitant with smaller placentas, and altered
placental structure at midgestation. No detectable changes in placental hemodynamics were observed, as determined by ultrasound biomicroscopy. An antiviral response was not evident in rat trophoblast stem (TS) cells following exposure to PolyI:C, or to
certain PolyI:C-induced cytokines including IL-6. However, TS cells expressed high levels of type I IFNR subunits (Ifnar1 and
Ifnar2) and responded to IFN-⍺ by increasing expression of IFN-stimulated genes and decreasing expression of genes associated
with the TS stem state, including Mest. IFN-⍺ also impaired the differentiation capacity of TS cells. These results suggest that an
antiviral inflammatory response in the conceptus during early pregnancy impacts TS cell developmental potential and causes
latent placental development and reduced fetal growth. The Journal of Immunology, 2020, 204: 694–706.

The Journal of Immunology

Materials and Methods
Animals
Female (6–8 wk) and male (8–10 wk) Sprague Dawley rats were obtained
from Charles River Laboratories and maintained in a 12-h light/12-h dark
cycle with food and water available ad libitum. Females were cycled by
daily inspection of cells within a vaginal lavage and mated when in proestrus with a fertile male. Gestational day (GD) 0.5 was defined as the day
immediately following mating if spermatozoa were detected within the
vaginal lavage. All protocols involving the use of rats were approved by
the University of Western Ontario Animal Care and Use Committee.

Experimental protocol and tissue collection
In the first set of experiments, pregnant rats received PolyI:C (1, 5, or 10 mg/kg;
Sigma-Aldrich) or sterile saline i.p. on GD8.5. Dams were sacrificed on
GD13.5 to assess for fetal viability. Based on these results, 10 mg/kg

PolyI:C was used in all subsequent experiments because there was no
difference in litter size or number of resorptions with any of the doses tested,
and it is a dose that has been previously used in pregnant dams to elicit longterm metabolic and neurodevelopmental problems in offspring (20–24).
For experiments in which fetal and placental growth were analyzed, dams
were sacrificed on GD8.5 (6 h after maternal saline or PolyI:C injection),
GD13.5 (5 d after maternal saline or PolyI:C injection), or GD18.5
(10 d after maternal saline or PolyI:C injection) using mild carbon dioxide
inhalation until respiratory failure, followed by cardiac puncture or decapitation. For tissues collected on GD8.5, whole conceptuses (containing
decidua, placenta, and embryo) were isolated and either snap-frozen in
liquid nitrogen or fixed in 10% neutral buffered formalin. For analysis of
placental and fetal weights on GD13.5 or GD18.5, uterine horns were
dissected to isolate whole conceptuses, preserved in 10% neutral buffered
formalin for 24 h, and then dissected to isolate and independently weigh
the fetus and placenta. Preservation was used to enhance the structural
integrity of fetal tissue, particularly for tissues isolated on GD13.5,
and ensure that residual fetal membranes were completely removed.
Fetal weights were consistent between fresh and fixed specimens. Fetal
crown-rump length was also measured using a digital caliper. For
cryosections, whole conceptuses were placed in dry ice–cooled heptane and stored at 280˚C until sectioned. For paraffin-embedded sections, whole conceptuses were fixed in 10% neutral buffered formalin
for at least 24 h, then transferred to 70% ethanol and stored at 4˚C prior
to sectioning.

RT-PCR
RNA was extracted from tissue by homogenizing in TRIzol (Thermo Fisher
Scientific). The aqueous phase was then diluted with 70% ethanol, placed on
RNeasy columns (Qiagen), treated with DNase I, and purified. RNA was
extracted from cells by lysing in TRIzol and proceeding as directed by the
manufacturer. cDNA was generated from purified RNA (50 ng/ml) using
High Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific),
diluted 1:10, and used for conventional RT-PCR or quantitative RT-PCR
(qRT-PCR). Conventional RT-PCR was conducted using primers described
in Table I, and DreamTaq DNA Polymerase (Thermo Fisher Scientific) to
amplify cDNA. Cycling conditions involved an initial holding step (95˚C
for 3 min), followed by 34 cycles of PCR (95˚C for 30 s, 55˚C for 30 s, and
72˚C for 1 min), and a final elongation phase at 72˚C for 5 min. PCR
products were resolved on 2% agarose gels and imaged using a ChemiDoc
imaging system (Bio-Rad Laboratories). For qRT-PCR, cDNA was mixed
with SensiFAST SYBR green PCR Master Mix (FroggaBio) and primers
described in Table I. A CFX Connect Real-Time PCR system (Bio-Rad
Laboratories) was used for amplification and fluorescence detection.
Cycling conditions were as follows: an initial holding step (95˚C for
3 min), followed by 40 cycles of two-step PCR (95˚C for 10 s, 60˚C for
45 s), then a dissociation step (65˚C for 5 s and a sequential increase to
95˚C). Relative mRNA expression was calculated using the comparative
cycle threshold (Ct) (DDCt) method. The geometric mean of Ct values
obtained from amplification of five constitutively expressed genes (Rn18s,
Ywhaz, Eef2, Gapdh, and Actb) was used as reference RNA. Ct values from
each of these genes were stable among the conditions tested.

Ultrasound
Ultrasound imaging and Doppler waveform recordings were used to
compare blood flow patterns in the maternal uterine artery and fetal umbilical vessels. Dams were anesthetized with inhaled isoflurane (4% induction, 1–3% maintenance). Body temperature was maintained at 36–38˚C
with a heating pad. Heart rate and respiratory physiology were monitored
throughout the imaging procedure. Hair was removed from the abdomen
by shaving, followed by application of a depilatory cream, after which a
coupling gel (37˚C) was applied. Rats were imaged transcutaneously using
a preclinical ultrasound imaging system (model Vevo 2100; FujiFilm
VisualSonics) coupled with MS-250 (20 MHz, uterine artery) and MS-400
(30 MHz, umbilical artery) MicroScan transducers. The transducer beam
angle was set to ,45˚ for all measurements. Doppler waveforms were
obtained from the uterine artery near the utero-cervical junction and from
the umbilical artery spanning the fetal–placental junction. Peak systolic
velocity (PSV) and end diastolic velocity (EDV) were manually measured
from three sequential cardiac cycles, and data were averaged. The resistance index (RI) (RI = [PSV 2 EDV]/PSV) was then calculated to quantify
the resistance of arterial blood velocity waveforms. Uterine artery measurements were recorded from nine dams per group; umbilical artery
measurements were conducted in at least two conceptuses from each of
these dams. The duration of anesthesia was limited to no more than 45
min. During this time, maternal and fetal circulatory parameters were not
noticeably affected.
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amino acids, glucose, and fatty acids, to the fetal circulation is
dependent on placental size, morphology, and blood flow (12).
Formation of the placenta begins shortly after blastocyst implantation and is contingent on proper proliferation and differentiation
of trophoblast stem (TS) cells. TS cells are multipotent progenitor
cells that specialize into heterogeneous trophoblast subtypes
that form the bulk of the placenta and perform various functions
required for fetal growth and pregnancy success. In humans, TS
cells differentiate into extravillous trophoblasts, which direct
maternal resources to the conceptus, and villous trophoblasts,
which specialize in nutrient transfer between maternal and fetal
blood. A similar dichotomous organization of the placenta occurs
in rodents, in which junctional zone and labyrinth zone trophoblasts perform analogous functions to extravillous and villous
trophoblasts, respectively (13). TS cell development and differentiation are adaptable and respond to changes in the surrounding
environment, including cellular stress and changes in oxygen and
nutrient delivery, providing the placenta a degree of plasticity
during its early development to facilitate embryo survival during
extrinsic challenges (14). Trophoblasts cultured from rodent
blastocysts and ectoplacental cones alter their survival and differentiation potential in response to IFNs (15–18), indicating that
inflammation may be an additional extrinsic challenge that can
impact placental morphology and fetal growth.
To determine the effect of systemic inflammation on placental
development and fetal growth, we injected rats with the viral mimic
polyinosinic:polycytidylic acid (PolyI:C) during early pregnancy.
PolyI:C is a synthetic analogue of dsRNA: a molecular pattern
produced by many viruses, either as the genetic material for some
RNA viruses or as an intermediate for viral RNA synthesis. PolyI:C
is a ligand for the pattern recognition receptors TLR3, retinoid acid
inducible gene-1 (RIG1), and melanoma differentiation-associated
gene 5, which enables mammalian cells to detect the presence of
viruses and initiate cellular antiviral responses, such as production
of IFNs (19). Given the purported immune tolerance mechanisms
evident within the conceptus during early pregnancy, we were
uncertain whether an antiviral response would be evident at this
site. We found that PolyI:C exposure during early pregnancy induced a robust antiviral response and hypoxia within the conceptus, close to the location of placental development. The
antiviral response was associated with reduced placental and fetal
size during middle and late pregnancy. Furthermore, we provide
evidence that rat TS cells are responsive to IFN-a, and IFN-a
exposure decreased expression of stem-related genes in these cells
and reduced their differentiation capacity. Our results suggest
that an IFN-mediated intrauterine antiviral response during early
pregnancy causes transient placental dormancy by inhibiting TS
cell developmental potential, resulting in smaller-than-normal
placentas and fetuses.
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Western blotting
Protein expression was evaluated by Western blotting. Total protein in
tissues was isolated by homogenizing snap-frozen GD8.5 conceptuses in
radioimmunoprecipitation assay lysis buffer (50 mM Tris, 150 mM NaCl,
1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.2) supplemented with protease inhibitor mixture (Sigma-Aldrich) and then
sonicated (Sonic Dismembrator Model 100; Thermo Fisher Scientific). A
modified bicinchoninic acid assay (Bio-Rad Laboratories) was used to
measure total protein concentrations. Approximately 25 mg of tissue lysates
were mixed with 43 loading buffer (final volume: 62.5 mM Tris, pH 6.8,
2% SDS, 10% glycerol, 0.025% bromophenol blue, 50 mM DTT), boiled
for 5 min, and subjected to SDS-PAGE. Proteins were then transferred to
polyvinylidene difluoride (PVDF) membranes, blocked with 3% BSA in
TBS containing 0.1% Tween-20, and probed with primary Abs specific for
STAT1 (catalog no. 14994, 1:1000; Cell Signaling Technology), VIPERIN
(catalog no. MABF106, 1:1000; Sigma-Aldrich), and IFN regulatory factor
(IRF) 1 (catalog no. 8478, 1:1000; Cell Signaling Technology). Expression
of GAPDH (catalog no. 5174, 1:1000; Cell Signaling Technology) was
used as a loading control. Following incubation with species-appropriate,
infrared-conjugated secondary Abs (Cell Signaling Technology), protein
signals were detected using a LI-COR Odyssey imaging system (LI-COR
Biotechnology).

Frozen conceptuses were embedded in Optimal Cutting Temperature
compound and cryosectioned at 10-mm thickness. Sections were fixed in
10% neutral buffered formalin, permeabilized using 0.3% Triton-X and 1%
BSA in PBS, and blocked in 10% normal goat serum (Thermo Fisher
Scientific). Sections were immersed in primary Abs specific for cytokeratin
(catalog no. 628602, 1:400; BioLegend) and vimentin (catalog no.
MA5-11883, 1:50; Invitrogen) overnight at 4˚C. After washing, sections
were immersed in species-appropriate biotin-conjugated secondary IgG
Abs followed by Vectastain ABC Elite reagent (Vector Laboratories),
and color was developed using 3-amino-9-ethylcarbazole (AEC) red
(Thermo Fisher Scientific). Sections were counterstained with Gill No. 1
hematoxylin (Sigma-Aldrich) and mounted using Fluoromount-G mounting medium (SouthernBiotech). Images were acquired using a Nikon
ECLIPSE Ni Series microscope equipped with a Ds-Qi2 camera. Placental
sections that were immunostained using vimentin (which is detectable in
labyrinth zone and uterine tissue but not in junctional zone and is therefore
useful for demarcating different placental zones) were subjected to
morphometric analysis using ImageJ software (25). The mean thickness
of the conceptus, placenta (junctional zone and labyrinth zone), and
each zone was calculated following three independent measurements
within the middle of the placenta. The mean area of each placenta and
zone was calculated following three independent measurements of the
perimeter. All measurements were conducted by two researchers who
were blinded to the experimental treatments, and results between observers were averaged.
To detect localization of perforin-containing cells on GD8.5, whole
conceptuses were collected, fixed in 10% neutral buffered formalin, embedded with paraffin, and sectioned at 5-mm thickness. Sections were
dewaxed in Histo-clear and rehydrated using increasing dilutions of ethanol. Formaldehyde crosslinks were broken by immersing sections in a
retrieval solution (Reveal Decloaker; BioCare Medical) heated to 95˚C for
20 min. Sections were then permeabilized using 0.3% Triton-X and 1%
BSA in PBS and blocked in 10% normal goat serum. Samples were immersed in primary Ab specific for rat perforin (catalog TP251, 1:400;
Torrey Pines Biolabs) overnight at 4˚C, followed by Alexa 555–conjugated
anti-rabbit secondary Ab for 1 h at room temperature. Sections were then
immersed in an Ab specific for cytokeratin (BioLegend) for 1 h, then
exposed to Alexa 488–conjugated anti-mouse secondary Abs, and mounted
using Fluoromount-G. Images were acquired using a Nikon ECLIPSE Ni
Series microscope equipped with a Ds-Qi2 camera. Sections were subjected to localization analysis using ImageJ software (25). The distance
between the bulk of perforin-positive cells and the tip of the ectoplacental
cone was measured in arbitrary units (pixels) and calculated relative to the
length of the ectoplacental cone.

Rat TS cell cultures
Blastocyst-derived rat TS cells (26) were used to evaluate the effects of
PolyI:C, or selected PolyI:C-induced cytokines, on trophoblast cell behavior. Rat TS cells were generously provided by Michael Soares (University of Kansas Medical Center, Kansas City, KS). Cells were cultured in
RPMI 1640 media (Life Technologies) supplemented with 20% (v/v) FBS
(Life Technologies), 100 mM 2-ME (Sigma-Aldrich), 1 mM sodium
pyruvate (Sigma-Aldrich), 50 mM penicillin, 50 U/ml streptomycin, fibroblast growth factor 4 (25 ng/ml; R&D Systems), and heparin (1 mg/ml;
Sigma-Aldrich). A total of 70% of the media was preconditioned by mitomycin C–treated mouse embryonic fibroblasts prior to being added to rat
TS cells. PolyI:C (50 mg/ml), recombinant rat IFN-a1 (100 U/ml or 1000
U/ml; R&D Systems), recombinant rat IL-6 (IL-6, 20 ng/ml; PeproTech),
or recombinant rat IFN-g (100 U/ml; PeproTech) was added to TS cells for
24 h. Transfection of PolyI:C (50 mg/ml) into rat TS cells was conducted
using lipofectamine 2000 (Thermo Fisher Scientific). To determine the
effect of IFN-a on trophoblast differentiation, rat TS cells were cultured
for 3 d as above but without mouse embryonic fibroblast-conditioned
media, fibroblast growth factor 4, activin A, or heparin and in the presence or absence of recombinant rat IFN-a1 (1000 U/ml). Media were
replaced daily.

Immunocytochemistry and EdU incorporation
Cells were fixed in 4% paraformaldehyde, permeabilized using 0.3%
Triton-X, and blocked using 10% normal goat serum (Life Technologies).
Cells were then immersed in anti-phospho-histone H3 Ab (1:1000, catalog
no. 3377P; Cell Signaling Technology), followed by goat anti-rabbit Alexa
Fluor 488–conjugated secondary Ab. Nuclei were then counterstained
using DAPI (Thermo Fisher Scientific). For EdU, rat TS cells were treated
with 10 mM EdU (ClickiT EdU Proliferation Kit; Thermo Fisher Scientific) for 6 h, followed by fixation as above. Detection of EdU was performed as per the manufacturer’s instructions, and nuclei were detected by
counterstaining with Hoechst. Cells were imaged with a Zeiss Axio fluorescence microscope. The total number of cells, and the number positive
for phospho-histone H3 or EdU, was then counted in three random nonoverlapping fields of view per well. The percentage of phospho-histone H3
and EdU-positive cells was then calculated by dividing the total number of
positive cells by the total number of cells, then multiplying by 100.

Statistical analysis
Values are expressed as mean 6 SEM. Unless indicated otherwise, statistical significance was analyzed by unpaired t test when comparing two
groups and one-way ANOVA with Tukey multiple comparisons test
when comparing three or more groups. All statistical tests were two
sided, and differences were considered significant when p # 0.05. All
animal experiments were conducted with a minimum of three dams.
The specific number of dams and conceptuses analyzed is indicated in
the figure legends.

Results

Detection of hypoxia

Maternal PolyI:C exposure triggers a potent antiviral response
within the conceptus during early pregnancy

To assess hypoxia in uterine and placental tissue after maternal PolyI:C
exposure, immunohistochemical staining for pimonidazole was performed.
Pimonidazole covalently binds to thiol groups in proteins of cells exposed
to hypoxia (pO2 , 10 mm Hg). Pimonidazole adducts can then be detected immunohistochemically to denote tissue areas exposed to hypoxic
conditions.

PolyI:C is an analogue of dsRNA, which is a molecular pattern
associated with viral infection and a well-known inducer of antiviral immune responses. The pregnant uterus and fetal–placental
unit are considered immune-privileged sites, so our first goal was
to determine whether systemic PolyI:C administration to pregnant
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Immunohistochemistry

Rats were i.p. injected with pimonidazole hydrochloride (hypoxyprobe1, 60 mg/kg; Natural Pharmacia) 2.5 h before sacrifice. After euthanasia,
whole conceptuses were collected, fixed in 10% neutral buffered formalin,
and embedded with paraffin. Paraffin-embedded tissues were then sectioned
at 5-mm thickness. Sections were dewaxed in Histo-clear and rehydrated
using increasing dilutions of ethanol. Formaldehyde crosslinks were broken by immersing sections in Reveal Decloaker, as described above. Endogenous peroxidases were then inhibited using 3% hydrogen peroxide in
PBS, and tissues were blocked in 10% normal goat serum. Sections were
incubated in hypoxyprobe-1 mouse mAb (clone 4.3.11.3, 1:50; Natural
Pharmacia), followed by biotin-conjugated anti-mouse secondary IgG Ab.
Following wash, samples were then immersed in Vectastain (Vector
Laboratories) for 30 min at room temperature, and color was developed
using AEC red (Thermo Fisher Scientific). Samples were counterstained
with Gill No. 1 hematoxylin (Sigma-Aldrich), mounted, and imaged as
above.

The Journal of Immunology

viral processes) in the conceptus 2, 6, and 12 h after injection and
increased IRF1 expression 2 and 6 h after injection. Both VIPERIN
and IRF1 are directly and rapidly activated by both PolyI:C and
IFNs and contribute to the cellular antiviral state (27). Injection of
PolyI:C also increased expression of STAT1 in the conceptus
12 and 24 h after maternal exposure (Fig. 1B). The relatively
longer time required for increased STAT1 expression in comparison with VIPERIN and IRF1 likely relates to the time required
for protein stabilization and accumulation following activation
(28). Collectively, these data indicate that maternal exposure to
PolyI:C during early pregnancy provokes a robust antiviral response near the site of placental and embryonic development.
We next assessed expression of nine maternally imprinted genes
associated with embryonic and placental growth and development
(29). In pregnant rats exposed to PolyI:C, we observed decreased
expression of mesoderm-specific transcript (Mest, 4-fold decrease), a gene highly associated with placental growth, as well as
secreted frizzled-related protein 2 (Sfrp2; 2.4-fold decrease) and
d-like noncanonical notch ligand 1 (Dlk1, 1.7-fold decrease,
Fig. 1C, all p , 0.05). Expression of Dio3 appeared to be decreased, although it did not reach statistical significance (p = 0.10,
not shown). No change in expression of MAGE family member L2
(Magel2; not shown), paternally expressed gene 3 (Peg3), paternally

FIGURE 1. Exposure of pregnant rats to PolyI:C elicits a robust antiviral response in the conceptus. RNA was isolated from the conceptus (containing
decidua, primordial placenta, and embryo) 6 h following maternal injection of 10 mg/kg PolyI:C or saline (0 mg/kg PolyI:C) on GD8.5. (A) Expression of
genes associated with antiviral responses after saline or PolyI:C exposure. (B) Protein levels of STAT1, VIPERIN, IRF1, and GAPDH are shown 2, 6, 12,
and 24 h following maternal PolyI:C exposure (10 mg/kg) or 2 h following maternal saline exposure (0 mg/kg). Uncropped images of Western blots are
provided in Supplemental Fig. 3. (C) Expression of maternally imprinted genes associated with fetal and placental growth after saline or PolyI:C exposure.
Results represent means 6 SEM. Data significantly different (p , 0.05) from controls are indicated by an asterisk (*) (n = 9 from three dams per group).
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dams elicited an antiviral response within the conceptus (referring
to decidualized uterine tissue along with primordial placenta and
embryo). Compared with pregnant rats administered saline, expression of genes encoding various antiviral factors was increased
within the conceptus 6 h after injecting pregnant rats with 10 mg/kg
PolyI:C, including IFN-a (Ifna, 3.3-fold increase), Il6 (11-fold
increase), Il1a (17-fold increase), Il1b (6-fold increase), c-x-c
motif ligand (Cxcl) 10 (Cxcl10; 323-fold increase), IRF 7 (Irf7,
22-fold increase), IDO (Ido1, 221-fold increase), radical SAM
domain-containing 2 (Rsad2; 166-fold increase), and Tlr3 (5-fold
increase, Fig. 1A, all p , 0.05, primer sequences provided in
Table I). Myxovirus resistance 1 (Mx1), which is an IFN-inducible
gene encoding a dynamin-like GTPase that confers an antiviral
state against a wide range of RNA viruses (including influenza A)
and some DNA viruses, was also highly upregulated in the conceptus following PolyI:C exposure (386-fold increase, Fig. 1A,
p , 0.05). A similar robust antiviral response was detected when
transcript levels were evaluated within isolated decidua following
maternal PolyI:C exposure.
Next, we determined whether PolyI:C altered expression of
select proteins associated with antiviral immune responses. PolyI:C
exposure to pregnant dams caused a rapid increase in RSAD2 (also
known as VIPERIN, which is a multifunctional protein that inhibits
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Table I. List of primers used for RT-PCR
Accession Number

Forward Sequence

Reverse Sequence

Size (kb)

Actb
Cdx2
Cxcl10
Dio3
Dlk1
Ddx58
Eef2
Gapdh
Gcm1
Id2
Ido1
Ifna
Ifnar1
Ifnar2
Igf2
Il1b
Il6
Il6r
Irf7
Isg15
Isg20
Magel2
Mest
Mx1
Plagl1
Peg3
Peg10
Pgf
Prl3b1
Rn18s
Rsad2
Sfrp2
Tlr3
Vegfa
Ywhaz

NM_031144.3
NM_023963.1
NM_139089.1
NM_017210.4
NM_053744.1
NM_001106645.1
NM_017245.2
NM_017008.4
NM_017186.2
NM_013060.3
NM_023973.1
NM_001014786.1
NM_001105893.1
XM_006248107.3
NM_001190162.1
NM_031512.2
NM_012589.2
NM_017020.3
NM_001033691.1
NM_001106700.1
NM_001008510.1
XM_001054803.6
NM_001009617.1
NM_001271058.1
NM_012760.3
NM_001304816.1
XM_008762737.1
NM_053595.2
NM_012535.3
NM_046237.1
NM_138881.1
NM_001276712.1
NM_198791.1
NM_001110333.2
NM_013011.3

59-AGCCATGTACGTAGCCATCC-39
59-GAGCACGGACACTGTGAGAA-39
59- TGTCCGCATGTTGAGATCAT-39
59- GCCTCTACGTCATCCAGAGC-39
59-GAGCTGGCGGTCAATATCAT-39
59-TCCTCCCACCTGTTTGAGAC-39
59-CGCTTCTATGCCTTCGGTAG-39
59- AGACAGCCGCATCTTCTTGT-39
59-CCTCAATGATTGCCTGTCCT-39
59-TGAAAGCCTTCAGTCCGGTG-39
59- CGTGGATCCAGACACCTTTT-39
59-GGTGGTGGTGAGCTACTGGT-39
59- ATTACGTGTTCTCCCCACCA-39
59-TGGCCCACAAATGTTCTTCT-39
59-CGGACGACTTCCCCAGATAC-39
59-AGGCTTCCTTGTGCAAGTGT-39
59-GCCAGAGTCATTCAGAGCAA-39
59-AGGGTGTCTGCTTCCTGCTA-39
59-CCTCTGCTTTCTGGTGATGC-39
59-GCCATGACCTGGAACCTAAA-39
59-TCTGAAAGGCAAGCTGGTG-39
59-TCCAGCCTGCCTCTACTGAT-39
59-CCATCGTCCTCTCCTTCTCC-39
59-CCTGAGGTAAGGCTGTGGAA-39
59-GGTGCTGCCTTTTCAGAGTC-39
59-CAGAATGAACTGGCAGACGA-39
59-GTTGACCGTGTCCGTGTATG-39
59-AGACGACAAAGGCAGAAAGG-39
59-ACCTGGAGCTGTTGGAAGTG-39
59-GCAATTATTCCCCATGAACG-39
59-GGGATGCTAGTGCCTACTGC-39
59-TGTCCGATAGGGACCTGAAG-39
59-GGTGGCCCTTAAAAGTGTGG-39
59-CAATGATGAAGCCCTGGAGT-39
59-TTGAGCAGAAGACGGAAGGT-39

59-CTCTCAGCTGTGGTGGTGAA-39
59-AGAAGCCCCAGGAATCACTT-39
59-GGGTAAAGGGAGGTGGAGAG-39
59-GCCCACCAATTCAGTCACTT-39
59-GCATAGAGGGAGCTGTGAGG-39
59-ACAAGCCATGTTAGGGGATG-39
59-GTAGTGATGGTGCCGGTCTT-39
59-CTTGCCGTGGGTAGAGTCAT-39
59-TCCAGGTTTGTGCTTCATCA-39
59-GAGCTTGGAGTAGCAGTCGT-39
59-GGCTGGAGGCATGTACTCTC-39
59-TTGAGCCTTCTGGATCTGCT-39
59-CGATTCTCCTCTCCAGCAAC-39
59-GTGCACCCTAATGCTGTCCT-39
59-CTGAACGCTTCGAGCTCTTT-39
59-TGAGTGACACTGCCTTCCTG-39
59-CATTGGAAGTTGGGGTAGGA-39
59-TTGTGAAAAGGCAAGCTCCT-39
59-GCGCTCAGTCATCAGAACTG-39
59-CTGCCTGATAAGGGCAACAC-39
59-TGGACGTGTCGTAGATGGTG-39
59-GACTTGGAAGCCTCTGCATC-39
59-TCCCGTCATTGTTGCGAATC-39
59-AATACGGCCCCACAAAACAC-39
59-CCACACTCAGTCTTGGAGCA-39
59-GGTGTAGGAGGGCCCATATT-39
59-GACGTCTGATCTTGCGTTTG-39
59-TCTCCTCTGAGTGGCTGGTT-39
59-GACAGGGATGGCTACTCAGC-39
59-GGCCTCACTAAACCATCCAA-39
59-CTGAGTCTCCTTGGGCTCAC-39
59-CGAGAAGCCACTCCACTAGG-39
59-GGTTTGCGTGTTTCCAGAGT-39
59-TTTCTTGCGCTTTCGTTTTT-39
59-CCTCAGCCAAGTAGCGGTAG-39

226
200
202
169
149
200
234
206
199
137
246
192
156
182
142
228
99
232
206
188
94
234
182
210
244
188
183
119
198
137
174
231
184
210
200

expressed gene 10 (Peg10), or insulin-like growth factor 2 (Igf2)
was detected in the conceptus after maternal exposure to PolyI:C
(Fig. 1C). Transcript levels of another maternally imprinted gene,
PLAG1-like zinc finger 1 (Plagl1), did not meet the threshold
detection levels (Ct . 30 cycles).
Maternal PolyI:C exposure is associated with acute hypoxia
within the conceptus during early pregnancy
To assess whether maternal administration of PolyI:C increased
tissue hypoxia within the conceptus, immunohistochemical detection of pimonidazole was used. Sections of the conceptus
collected from saline-injected dams showed moderate levels of
pimonidazole immunoreactivity, indicative of hypoxic regions
proximate to the primordial placenta (Fig. 2). In comparison,
following maternal PolyI:C administration, pimonidazole immunoreactivity was noticeably more intense, suggesting that PolyI:C
administration altered tissue oxygenation (Fig. 2). Likewise, maternal administration of PolyI:C was also associated with a 1.7-fold
increase in hypoxia-inducible factor 1 a (Hif1a) transcript levels,
and a 2-fold increase in transcript levels of the hypoxia-inducible
gene Vegfa within conceptuses (Fig. 2C, p , 0.05).
The pregnant uterus contains an abundant population of perforincontaining uterine NK cells. PolyI:C alters the activation of uterine
NK cells (30, 31), so we sought to examine whether maternal
PolyI:C exposure during early pregnancy alters localization of
these cells. In dams injected with saline, perforin-containing
cells were abundant within the decidua, but few cells were detectable close to the site of placental development. Following
injection of PolyI:C, there appeared to be an accumulation of
perforin-positive cells adjacent to the nascent placenta in some

conceptuses. However, the effect was variable, and we were unable to detect a statistically significant difference in the distance
separating perforin-positive cells from the nascent placenta
(Supplemental Fig. 1). Collectively, these results indicate that
maternal PolyI:C exposure during early pregnancy alters the
decidual microenvironment during development of the nascent
placenta and embryo.
Maternal PolyI:C exposure during early pregnancy is
associated with reduced fetal weight at mid and late gestation
After determining that maternal PolyI:C administration during
early pregnancy triggered a robust antiviral response and tissue
hypoxia within the conceptus, our next goal was to examine fetal
growth and survival 5 and 10 d after maternal exposure to PolyI:C.
On GD13.5, average fetal weight was decreased by 10% in dams
exposed to PolyI:C in early pregnancy compared with those exposed to saline (Fig. 3A, p , 0.05). Similarly, fetal crown-rump
length was reduced by 9% following maternal PolyI:C exposure
(Fig. 3B, p , 0.05). Because fetal growth is often referenced to
percentiles for a given gestational age and babies smaller than the
10th centile are typically considered small for gestational age, we
characterized the distribution of control GD13.5 fetuses using the
saline-treated group to generate percentiles. Fetuses falling below
the 10th percentile (0.068 g weight; 8.17 mm crown-rump length)
were considered FGR. Strikingly, maternal PolyI:C exposure
during early pregnancy caused 73% of fetuses to fall below the
FGR threshold in weight and 52% to fall below the FGR threshold
in crown-rump length (Fig. 3A, 3B, p , 0.05). On GD18.5, fetal
body weight and crown-rump length remained smaller in dams
exposed to PolyI:C, although these effects were more modest in

Downloaded from http://www.jimmunol.org/ by guest on August 8, 2022

Gene

The Journal of Immunology

699

comparison with that which was observed on GD13.5 (decreased
by 9 and 2% compared with saline-treated dams, respectively,
Fig. 3C, 3D, p , 0.05), suggesting that these fetuses had some
degree of catch-up growth. Using the same percentile strategy to
characterize distribution of control GD18.5 fetuses, we observed a
greater percentage of fetuses with weights and crown-rump lengths
below the 10th centile when dams were exposed to PolyI:C 10 d
earlier (43% in weight, 16% in crown-rump length, Fig. 3C, 3D,
p , 0.05). In line with the smaller overall fetal size, maternal
PolyI:C exposure was associated with smaller fetal liver weights
(9% decrease, p , 0.05) and fetal brain weights (10% decrease,
p , 0.05) compared with saline-injected dams (Fig. 3E). Surprisingly, we did not observe any significant difference in litter size, as
well as number of viable or resorbed fetuses, indicating that PolyI:C
did not affect fetal survival (Fig. 3F). Thus, maternal exposure
to PolyI:C during early gestation is associated with delayed or
impaired fetal growth at mid and late gestation without affecting
viability.
Maternal PolyI:C exposure results in smaller placentas
Proper development of the placenta is fundamental for supporting
fetal growth throughout pregnancy. Because maternal PolyI:C
exposure induced a potent antiviral response within the conceptus
and was associated with reduced fetal growth, we next evaluated
the effect of PolyI:C on placental growth and development. As
illustrated schematically in Fig. 4A, the rodent placenta is composed of three distinct zones. The labyrinth zone is situated
closest to the chorionic plate (and, hence, the fetus) and is specialized to promote nutrient and gas transfer between maternal
and fetal blood. The middle layer is the junctional zone, which
forms the interface between maternal and fetal tissue. The maternal portion of the placenta includes the decidua and mesometrial triangle, which contain a variety of cell types (e.g.,
stromal cells, blood vessels, leukocytes) that support placentation
and pregnancy outcome.

We did not observe a noticeable difference in the composition of
the maternal portion of the placenta 5 d following exposure to
PolyI:C. Specifically, there was no evident change in the area or
thickness of the decidua or mesometrial triangle, number or localization of NK cells, blood vessels, or the depth of trophoblast
invasion between saline- or PolyI:C-exposed dams on GD13.5.
However, in dams exposed to PolyI:C on GD8.5, average placental
weight, area, and thickness were reduced on GD13.5 (15, 10, and
8% decreased compared with saline-treated dams, respectively;
Fig. 4, p , 0.05 for all), concomitant with reduced area and
thickness of the junctional zone (12 and 17%, respectively, Fig. 4,
p , 0.05) and labyrinth zone (14 and 6%, Fig. 4, p , 0.05). Interestingly, the effects of maternal PolyI:C exposure on placental structure were transient, as there were no differences
in placental weights, zonal areas, or thicknesses on GD18.5
(Supplemental Fig. 2). Collectively, these results suggest that
PolyI:C exposure during early pregnancy is associated with a
transient impairment or delay in development of the fetal
components of the placenta.
To assess whether placental hemodynamics were altered on
GD13.5 following maternal PolyI:C exposure, ultrasound biomicroscopy was performed to measure blood flow in uterine and
umbilical vasculature. There were no statistically significant differences in blood flow through the uterine artery 5 d after maternal
exposure to PolyI:C, as determined by average PSV, EDV, RI,
and velocity time integral (VTI) (Fig. 5A). In the umbilical artery,
there was no difference detected when measuring EDV, RI, heart
rate, and VTI. We did note a modest 23% increase in PSV 5 d after
maternal exposure to PolyI:C (Fig. 5B, p , 0.05), although in
the absence of a statistical difference in other umbilical vessel
parameters, we are unable to conclude whether this difference has
important implications for placental function and fetal growth
(32). Collectively, these results demonstrate efficient hemodynamics of the placenta following early gestational exposure to
PolyI:C despite their smaller size.
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FIGURE 2. Detection of hypoxia in the conceptus following maternal exposure to PolyI:C.
(A) Hypoxia was detected in sections of the
conceptus collected 6 h following maternal
PolyI:C (10 mg/kg) or saline (0 mg/kg) exposure
using hypoxyprobe. The black boxes surround
the ectoplacental cone (part of the primordial
placenta), and a higher magnification image is
shown in (B). Scale bar in (A), 1000 mm. Scale
bar in (B), 100 mm. (C) Transcript levels of Hif1a
and Vegfa 6 h following saline or PolyI:C exposure. Results represent means 6 SEM. Data
significantly different (p , 0.05) from controls
are indicated by an asterisk (*) (n = 9 from three
dams per group).
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IFN-a promotes an antiviral response in rat TS cells and
disrupts stem cell traits
PolyI:C is capable of directly inducing expression of genes associated with cellular antiviral responses. PolyI:C also robustly
stimulates production of cytokines, such as type I IFNs and IL-6,

Discussion
In this study, we show that maternal exposure to a viral stimulus
during formation of the nascent placenta is associated with a robust
antiviral response and hypoxia at the site of placental development,
concomitant with reduced placental and fetal growth trajectories.
We further found that TS cells express type I IFNR and respond
to IFN-⍺ by increasing IFN regulatory gene expression and decreasing expression of genes associated with the TS cell stem
state. TS cells also exhibit impaired differentiation potential in the
presence of IFN-⍺. Together, these results suggest that antiviral
inflammation early in pregnancy impairs proper TS cell function
and causes latent placental development and fetal growth.
Viral infections during pregnancy can result in a variety of
perinatal outcomes. In some cases, a viral infection may have no

Downloaded from http://www.jimmunol.org/ by guest on August 8, 2022

FIGURE 3. Maternal PolyI:C treatment early in pregnancy is associated
with decreased fetal size at mid and late pregnancy. Following maternal
administration of saline (0 mg/kg) or PolyI:C (10 mg/kg) on GD8.5, litters
were collected on GD13.5 (A, B, and F) or GD18.5 (C–E). Fetal weight
(A and C) and crown-rump length (B and D) were analyzed. (E) Fetal brain
and liver weights were measured. (F) Litter size and number of resorptions
are presented. Results represent means 6 SEM. Data significantly different
from controls (p , 0.05) are indicated by an asterisk (*) (n = 35 saline and
n = 53 PolyI:C from at least six dams on GD13.5; n = 58 saline and n = 81
PolyI:C from at least six dams on GD18.5).

which have pleiotropic effects on various cell types and mediate
antiviral inflammation. Therefore, our next goal was to determine
whether PolyI:C, type I IFNs, or IL-6 induce an antiviral response
in TS cells. Treatment of rat TS cells with PolyI:C or IL-6 did not
alter expression of genes associated with antiviral responses, including Rsad2, Cxcl10, Irf7, Isg15, and Isg20. Because some cell
types only respond to PolyI:C if it is present within the cytosol
(19), we transfected PolyI:C into rat TS cells but still did not
observe any change in expression of these genes (data not shown).
Likewise, exposure of rat TS cells to 100 U/ml IFN-g (a type II
IFN that is constitutively expressed in the conceptus during early
pregnancy, owing to the prevalence of uterine NK cells) did not
affect expression of any of these genes in TS cells. Conversely,
exposure of rat TS cells to 100 U/ml IFN-⍺ stimulated expression
of Cxcl10 (2.6-fold), Rsad2 (7.1-fold), Irf7 (11.6-fold), Isg15
(24-fold), and Isg20 (2-fold, Fig. 6A, all p , 0.05). In line with
these results, robust expression of type I IFNR subunits Ifnar1 and
Ifnar2 was detected in rat TS cells, whereas expression of IL-6R
and the PolyI:C receptors Tlr3 and Ddx58 (which encodes RIG1)
were low or undetectable (Fig. 6B). To further evaluate the responsiveness of TS cells to IFN-⍺, cells were exposed to low-dose
(100 U/ml) or high-dose (1000 U/ml) IFN-⍺. IFN-⍺ stimulated
expression of Cxcl10, Rsad2, Irf7, and Isg20 in a dose-dependent
manner, with 1000 U/ml IFN-⍺ increasing expression of these
genes by 7.34-fold, 39-fold, 38-fold, and 2.97-fold, respectively.
Both doses of IFN-⍺ stimulated Isg15 expression ∼30-fold
(Fig. 6C, p , 0.05).
After deducing that IFN-⍺ stimulates an antiviral response in TS
cells, our next goal was to determine whether IFN-⍺ disrupts TS
cell behavior. First, we evaluated proliferation in TS cells and
found that there was no statistically significant change in proliferation as determined by percentage of cells that incorporated
EdU (Fig. 7A, 7B) or that were positive for phospho-histone H3
(data not shown). We next evaluated expression of genes associated with maintaining the TS cell stem state and found that 1000
U/ml IFN-⍺ decreased transcript levels of Cdx2 (22%) and Mest
(14%, Fig. 7C, p , 0.05). There was no statistically significant
change in the expression of Id2. When TS cells were cultured in
differentiation conditions, expression of the labyrinth-associated
gene glial cells missing-1 (Gcm1) was increased by 5.3-fold,
and the trophoblast giant cell–associated gene prolactin family 3,
subfamily b, member 1 (Prl3b1; also called placental lactogen 2)
was increased by 2.4-fold (Fig. 7D, both p , 0.05). However, in
the presence of IFN-⍺, expression of Gcm1 was reduced by 78%,
and Prl3b1 levels were reduced by 63% compared with cells not
exposed to IFN-⍺ (Fig. 7D, both p , 0.05). Thus, IFN-⍺ disrupts
expression of a subset of genes required to maintain TS cells in a
stem state and inhibits their capacity to undergo differentiation
into specialized trophoblast lineages.
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apparent effect on the health of a fetus or newborn, whereas in other
cases, spontaneous abortion, FGR, or severe congenital anomalies
may result. The different outcomes likely relate to the type of virus,
the time during pregnancy when the infection is active, and whether
the pathogen is transmitted to the fetus (such as with toxoplasmosis,
other, rubella, CMV, and HSV infections, which are major causes of
congenital anomalies) (33). Aside from toxoplasmosis, other, rubella, CMV, and HSV infections, the effect of viral inflammation
on fetal and placental growth and development is poorly understood. Consequently, there is currently no standard of care for
managing viral infections during pregnancy, despite the increased
susceptibility of pregnant women to severe illness and mortality
from viral infections (34). In this study, we sought to investigate
the effect of viral inflammation on pregnancy outcome using the
synthetic dsRNA molecule, PolyI:C. Because PolyI:C is a TLR3
ligand and robust stimulator of antiviral inflammation (19), the
use of PolyI:C provides a means to elucidate the contribution of
antiviral inflammation to pregnancy outcome in the absence of a
pathogen. Previous studies have reported adverse pregnancy outcomes after administering PolyI:C to pregnant rodents, including
embryonic lethality (18, 30, 35, 36), preeclampsia-like symptoms
(5), preterm birth (37), and neurodevelopmental impairments in
offspring (38). The novelty of our study is that we administered
PolyI:C during early pregnancy prior to formation of the definitive
placenta and then evaluated acute inflammation in the conceptus
as well as placental and fetal growth throughout pregnancy. Because administration of PolyI:C to mice early in pregnancy results
in embryonic lethality (18, 30, 35, 36), it was surprising that, in
our hands, fetal viability was unaffected when rats were exposed
to a similar dose per weight of PolyI:C, despite a robust antiviral

response and hypoxia at the placentation site. Species differences
in PolyI:C-TLR3 signaling responses have been reported (39), so
these results may reveal differing susceptibility or sensitivity to
PolyI:C between mice and rats. The use of rats may thus provide
an advantage to study the effects of prenatal exposure to viral
inflammation early in pregnancy on long-term placental function,
fetal development, and offspring health without confounding
embryonic demise. Our results that inflammation rather than viral
burden affects early placental development and pregnancy outcome are consistent with other studies. For instance, exposure of
pregnant immunocompetent mice to Zika virus early in pregnancy,
prior to formation of the definitive placenta, causes placentation
defects and adverse pregnancy outcomes despite rare detection of
virus in the fetus or placenta. Interestingly, these adverse effects
were limited to infection during early pregnancy and were less
robust when the virus was administered at midpregnancy, when
the placenta is functional (40). Thus, antiviral inflammation during
early pregnancy may be a strong independent contributor to deficient placentation and adverse pregnancy outcomes regardless of
pathogenic burden.
Proper fetal growth is an essential determinant of prenatal and
perinatal health. Babies born growth restricted have a decreased
chance of surviving their first year and have a higher risk of
cardiovascular, metabolic, and neurodevelopmental sequelae in
later life (10). FGR can be classified as symmetric (whole body) or
asymmetric (head sparing). Asymmetric FGR is often due to extrinsic events (e.g., placental insufficiency, uterine anomalies)
occurring late in pregnancy that cause more severe growth impairments in abdominal organs than the head. Symmetric FGR, in
contrast, is usually attributed to an early embryonic event that
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FIGURE 4. Changes in placental morphology and size following maternal PolyI:C exposure. (A) Schematic representation of a GD13.5 placenta. (B)
Representative images of placentas collected on GD13.5 5 d after dams were injected with saline (0 mg/kg) or PolyI:C (10 mg/kg). Scale bar, 1000 mm. (C)
Placentas were collected on GD13.5 and weighed, and sections were immunostained with vimentin to analyze area and thickness of the placenta, labyrinth
zone (LZ), and junctional zone (JZ). Results represent means 6 SEM. Data significantly different from controls (n $ 18 placentas from six dams, p , 0.05)
are indicated by an asterisk (*).
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causes all growth parameters to be below normal for gestational
age. We observed that fetal weight was symmetrically decreased
in later pregnancy when dams were exposed to PolyI:C during
early gestation. We found no evidence of aberrant placental hemodynamics based on Doppler ultrasound recordings; thus,
PolyI:C-induced FGR is unlikely to be attributed to alterations in
placental blood flow dynamics. Therefore, viral inflammation reduced placental and fetal growth but did not impair placental
hemodynamics, which are phenotypes consistent with symmetric
FGR (41).
Viruses can be a major detriment to placental development.
Viral infections have been associated with increased trophoblast
apoptosis, decreased trophoblast invasion, production of proinflammatory responses, disruption of placental endocrine function,
and increased risk of obstetric complications (42–46). Our findings
using PolyI:C suggest that antiviral inflammation is sufficient to
impair placentation and is consistent with other studies. For example, administration of PolyI:C to pregnant mice elicits maternal decidual leukocyte activation, decidual necroptosis, and
production of TNF-a and IL-6 that induces STAT3 activation
and endocrine disruption in placental cells (30, 31, 47). Prenatal
PolyI:C exposure early in pregnancy also stimulates expression of
IFN-induced transmembrane proteins, which interferes with trophoblast syncytialization and labyrinth zone formation, leading to
embryo demise. Interestingly, mice lacking these transmembrane
proteins are protected from PolyI:C-induced placental maldevelopment and embryonic loss, implicating placental maldevelopment as a critical determinant causing adverse pregnancy outcomes
during viral inflammation (18). In rats, PolyI:C administration at

midgestation is associated with altered expression of amino acid
and drug transporters in the placenta, resulting in a corresponding
change in amino acid concentrations in the fetus (48, 49). Term
human placental explants also exhibit altered expression and
function of multidrug resistance transporters following challenge
with PolyI:C (50). In our study, we noted decreased expression of
several maternally imprinted genes associated with placental and
fetal growth after maternal PolyI:C exposure, including Sfrp2,
Dlk1, and Mest. Sfrp2 encodes a cysteine-rich protein that acts as a
regulator of placental development through its modulation of the
Wnt signaling pathway (51). Dlk1 encodes a cell-surface transmembrane protein highly expressed in placental villi and exhibits
reduced expression in FGR (52). Mest is expressed mainly by the
placenta. Mice lacking Mest exhibit FGR because of a severe
placental growth defect (53), and decreased expression of Mest is
evident in human placentas during FGR (54). Our results are
consistent with studies in which pregnant mice were challenged
with a bacterial infection (Campylobacter rectus) early in pregnancy, resulting in FGR associated with repression of key developmental genes, including several imprinted genes (55, 56). Thus,
it is possible that the latent fetal and placental growth observed
after PolyI:C exposure is at least partially due to altered expression of key placental growth-promoting genes like Mest.
Recognition of dsRNA by pattern recognition receptors triggers
an antiviral response that features synthesis of type I (a, b) IFNs.
Type I IFNs are a family of 13 cytokines that bind to a single
heterodimeric IFN-aR composed of two subunits, IFNAR1
and IFNAR2. Binding of type I IFNs to IFNAR initiates downstream signaling cascades that regulate activation and repression
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FIGURE 5. Effect of maternal PolyI:C exposure on uterine or umbilical artery blood flow. At GD13.5, 5 d after maternal exposure to saline (0 mg/kg) or
PolyI:C (10 mg/kg), blood flow was evaluated by ultrasound biomicroscopy in uterine (A) and umbilical (B) arteries. VTI, PSV, and EDV were measured,
and RI was calculated. Results represent means 6 SEM. Data significantly different from controls (n = 9 dams for uterine artery, n $ 23 fetuses from nine
dams for umbilical artery, p , 0.05) are indicated by an asterisk (*). B, bladder; F, fetus; P, placenta.
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of hundreds of genes (57). The products of these genes promote a
cellular antiviral state designed to limit replication and spread of
viruses and other pathogens and can also alter cell proliferation,
health, and viability in a cell-type and environment-specific context. The importance of type I IFNs for mediating systemic responses to viruses (and PolyI:C) in pregnant rodents is elegantly
demonstrated in Ifnar2/2 mice (36, 58, 59). Type I IFNs also alter
stem cell traits in pluripotent and hematopoietic stem cells
(60–62), so we postulated that type I IFNs impact TS cell behavior. We found that rat TS cells expressed high levels of Ifnar1
and Ifnar2 and robustly responded to IFN-a by increasing expression of various IFN-stimulated genes. IFN-a also decreased
expression of genes associated with the TS cell stem state and
placental growth, including Mest, and impaired their differentiation potential, as shown by reduced expression of Gcm1 and
Prl3b1. Thus, similar to reports with pluripotent and hematopoietic stem cells, type I IFN signaling may interfere with signal
transduction pathways that maintain TS cell stem traits and temporarily disrupt normal TS cell function in the nascent placenta.
Conversely, rat TS cells expressed low levels of Tlr3, Ddx58, and
Il6r, and no detectable changes in IFN-stimulated genes were
observed after rat TS cells were exposed to PolyI:C, IL-6, or
to another IFN constitutively expressed at the placentation site,
IFN-g. These results are interesting because human and murine
trophoblasts respond directly to PolyI:C, IL-6, and IFN-g (63–65).
Multiple cell types at the maternal-placental interface are capable
of recognizing pathogen-associated molecular patterns, such as
PolyI:C, and promote an antiviral state in part by producing type I
IFNs. Our data suggest that TS cells are unable to recognize
PolyI:C and some other inflammatory cytokines but possess the
capacity to respond to type I IFNs. The narrow scope of TS cell

responsiveness to viral patterns and cytokines other than type I
IFNs may be a protective mechanism to avoid unwanted disruption of normal cellular functioning or viability while still contributing to an aggregate antiviral state. As they differentiate into
specialized trophoblast lineages, trophoblasts may gain the capacity to recognize and respond to a broader range of immune
mediators to limit pathogen replication and vertical transmission.
Nonetheless, production of IFN-a in response to a viral infection
early in pregnancy may be a determinant of acute changes in TS
cell function, which could have long-lasting impacts on placental
and fetal growth.
This study has several limitations. First, although humans
and rats exhibit hemochorial placentation featuring regions
with analogous structure and function (66), there are key differences in early placental development between these species.
Therefore, we cannot conclude whether viral inflammation early
in pregnancy affects human placental development in the same
way as we observed for rat placentation. Of note, women diagnosed with primary CMV infection between 11 and 15 wk of
pregnancy exhibit progressively increased placental thickness,
as demonstrated through ultrasound examination (67), rather
than decreased placental size, as would be suggested by our
study. Potential explanations for this discrepancy are that CMV
infection was detectable only after the placenta was formed
and functional. In our study, the viral stimulus was provided
during early placental development prior to chorioallantoic
fusion. Thus, the timing of viral stimulus may be an important consideration. Moreover, the chronic CMV infection and
relatively long duration of pregnancy in humans may have facilitated either a progressive edematous and inflammatory
response or a placental compensatory response, resulting in a
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FIGURE 6. IFN-⍺ promotes an antiviral response in rat TS cells. (A) Rat TS cells were exposed to 100 U/ml IFN-⍺, 20 ng/ml IL-6, 100 U/ml IFN-g,
and 50 mg/ml PolyI:C for 24 h. The expression of five representative antiviral genes (Cxcl10, Rsad2, Irf7, Isg15, and Isg20) was analyzed using qRT-PCR.
Expression levels were calculated relative to five transcripts (Rn18S, Ywhaz, Eef2, Gapdh, Actb). The horizontal dotted line represents control rat TS cells
that were not exposed to cytokines. (B) Expression of receptors that interact with PolyI:C (Tlr3, Ddx58), type I IFNs (Ifnar1, Ifnar2), and IL-6 (Il6r)
were examined in rat TS cells by RT-PCR. (C) Rat TS cells were exposed to low-dose (100 U/ml) and high-dose (1000 U/ml) IFN-⍺, and expression of
antiviral genes was assessed by qRT-PCR. Results represent means 6 SEM. Data significantly different from controls (n = 3, p , 0.05) are indicated by an
asterisk (*).
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thicker placenta that would not be apparent in our postmortem
analyses in rats.
A second limitation is that we cannot ascertain that altered TS
cell function in response to type I IFNs is directly responsible for
the reduction in placental and fetal size after maternal PolyI:C. In
future studies, these experiments could be performed using a line of
rats in which the Ifnar gene is compromised by targeted genomic
editing (68). Third, because PolyI:C was administered to dams
systemically, we cannot conclude whether the concentration of
dsRNA at the maternal-placental interface in our model represents
the amount present within a typical virus infection. We attempted
to evaluate the presence of dsRNA at the maternal-placental interface by immunofluorescence using a mAb (J2), but we were
unable to detect robust staining. However, the profile of antiviral
factors induced at the maternal-placental interface that was observed in our study is consistent with previous results that have
used live viruses, such as Zika and influenza A (69–71), suggesting that the dose of PolyI:C used in our study elicits antiviral
inflammation at the maternal-placental interface that is comparable to inflammation present during a virus infection.
Exposure of pregnant rodents to PolyI:C is frequently used as a
model of brain maldevelopment and cognitive deficiencies in
offspring (38), which is consistent with the known association
between viral infections during pregnancy and increased risk of
neurobehavioral impairments in humans (72). FGR is also an
established risk factor for neurodevelopmental and behavioral
problems in childhood (73). Thus, our findings provide a new
dimension to the link between viral infections and FGR and
raise the question of whether altered placental and fetal growth

trajectories are causally linked to long-term neurobehavioral
consequences. Our results may also help to stratify those pregnancies at risk for poor fetal growth following exposure to a viral
infection by evaluating expression of genes associated with placental growth (e.g., Mest) so that targeted management strategies
can be implemented to alleviate long-term health sequelae.
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